Anti-Cancer Drug Delivery Agents

Most explored approaches to developing cell-based Anti-Cancer drug delivery systems (DDSs) are the encapsulation of the drug into the cells, cell surface modification, genetic modification of cells to secrete desired therapeutic proteins, and generating new biosynthetic systems. Tumour-tropism of mesenchymal stem cells (MSCs), as reveal in many studies, can be incorporate with expropriating engineering with anticancer genes to authorize their utilization in anticancer therapy. Furthermore, MSCs can be filled with nanoparticles (NPs), procure transport across the blood-brain barrier and accumulation of anticancer agent at the tumour site.

    Related Conference of Anti-Cancer Drug Delivery Agents

    Anti-Cancer Drug Delivery Agents Conference Speakers